Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective This study compared the acute phase (12-week) efficacy of fluoxetine versus placebo for the treatment of the depressive symptoms and the drinking of adolescents with comorbid major depression (MDD) and an alcohol use disorder (AUD). We hypothesized that fluoxetine would demonstrate efficacy versus placebo for the treatment of both the depressive symptoms and the drinking of comorbid MDD/AUD adolescents. Methods We conducted the first double-blind placebo-controlled study of fluoxetine in adolescents with comorbid MDD/AUD. All participants in both treatment groups also received intensive manual-based cognitive behavioral therapy (CBT) and motivation enhancement therapy (MET). Results Fluoxetine was well tolerated in this treatment population. No significant group-by-time interactions were noted for any depression-related or drinking-related outcome variable. Subjects in both the fluoxetine group and the placebo group showed significant within-group improvement in both depressive symptoms and level of alcohol consumption. End-of-study levels of depression and drinking were low in both treatment groups. Conclusions The lack of a significant between-group difference in depressive symptoms and in drinking may reflect limited medication efficacy, or may result from limited sample size or from efficacy of the CBT/MET psychotherapy. Large multi-site studies are warranted to further clarify the efficacy of SSRI medications in this adolescent MDD/AUD population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485
Brent, D. A. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210125017 · Cited by 753 · cited 1×
“The Cognitive Behavior Therapy for depression used in this studyutilized the widely used techniques of cognitive therapy that have been adapted for treatment of adolescent depression, as described by Brent et al. (1997).”
Method(2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1132 · Cited by 752
Rohde, P., Lewinsohn, P. M., & Seeley, J. R. (1991) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.100.2.214 · Cited by 440
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents
Emslie, G. J., Kennard, B. D., Mayes, T. L., Nightingale-Teresi, J., Carmody, T., Hughes, C. W., Rush, A. J., Tao, R., & Rintelmann, J. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091453 · Cited by 188
Cited by
Boden, J. M., & Fergusson, D. M. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03351.x · Cited by 1,233
Newer generation antidepressants for depressive disorders in children and adolescents
Hetrick, S. E., McKenzie, J. E., Cox, G. R., Simmons, M. B., & Merry, S. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004851.pub3 · Cited by 291
Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
Cornelius, J. R., Bukstein, O. G., Douaihy, A. B., Clark, D. B., Chung, T. A., Daley, D. C., Wood, D. S., & Brown, S. J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.05.010 · Cited by 105
Self-citationCox, G. R., Callahan, P., Churchill, R., Hunot, V., Merry, S. N., Parker, A. G., & Hetrick, S. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008324.pub2 · Cited by 70
Motivational interviewing to reduce substance use in adolescents with psychiatric comorbidity
Brown, R. A., Abrantes, A. M., Minami, H., Prince, M. A., Bloom, E. L., Apodaca, T. R., Strong, D. R., Picotte, D. M., Monti, P. M., MacPherson, L., et al. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.06.016 · Cited by 42
“…use treatment services in the community, only a few treatment studies have included samples of adolescents with comorbid psychiatric and substance disorders (e.g., Cornelius et al., 2009, 2010; Deas, Randall, Roberts, & Anton, 2000; Thurstone, Riggs, Salomonsen-Sautel, & Mikulich-Gilbertson, 2010).”
BackgroundBeaulieu, S., Saury, S., Sareen, J., Tremblay, J., Schütz, C. G., McIntyre, R. S., & Schaffer, A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400105 · Cited by 38
“55 A recent 12-week, double-blind, RCT evaluating efficacy of fluoxetine vs placebo in adolescents and young adults (21.1 ± 2.4 years; N = 70) with comorbid MDD and cannabis use disorder failed to demonstrate greater efficacy of fluoxetine (n = 36) compared with placebo (n = 34) for treating either…”
InfluentialRohden, A. I., Benchaya, M. C., Camargo, R. S., Moreira, T. D. C., Barros, H. M. T., & Ferigolo, M. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.03.017 · Cited by 35
Interventions for Substance Use Disorders in Adolescents: A Systematic Review
Steele, D. W., Becker, S. J., Danko, K. J., Balk, E. M., Saldanha, I. J., Adam, G. P., Bagley, S. M., Friedman, C., Spirito, A., Scott, K., et al. (2020) · doi:10.23970/ahrqepccer225 · Cited by 34
Babowitch, J. D., & Antshel, K. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.018 · Cited by 30
Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder
Hinckley, J. D., & Riggs, P. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.02.006 · Cited by 27
Treatments for Co-Occurring Depression and Substance Use in Young People: A Systematic Review
Deady, M., Teesson, M., & Kay-Lambkin, F. (2014) · Current Drug Abuse Reviews · doi:10.2174/1874473707666141015220608 · Cited by 25
“Depression was assessed using versions of the Structured Clinical Interview for DSM-IV [SCID; 118, 119] in two studies [108, 114] and the Child Schedule for Affective Disorders and Schizophrenia [K-SADS; 120, 121] in six studies [109-113, 115], the Diagnostic Interview Schedule for Children [122] in one study [116] an…”
BackgroundMethodInfluentialScott, K., Becker, S. J., Helseth, S. A., Saldanha, I. J., Balk, E. M., Adam, G. P., Konnyu, K. J., & Steele, D. W. (2022) · Family Practice · doi:10.1093/fampra/cmab096 · Cited by 3
Metadata
- Authors
- Cornelius, J. R., Bukstein, O. G., Wood, D. S., Kirisci, L., Douaihy, A., & Clark, D. B.
- Venue
- Addictive Behaviors
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 34
- Issue
- 10
- Pages
- 905-909
- ISSN
- 0306-4603 (ISSN-L)
- OpenAlex
- W2007328738
- Cited by
- 79
- References
- 6
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.